S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
S&P 500   3,125.91 (-3.10%)
DOW   27,045.23 (-3.27%)
QQQ   215.28 (-2.76%)
AAPL   289.42 (-2.94%)
FB   197.36 (-1.68%)
MSFT   168.22 (-1.56%)
AMZN   1,967.02 (-2.10%)
CGC   19.61 (-3.45%)
BABA   205.06 (-0.53%)
MU   51.98 (-5.51%)
GE   11.20 (-5.56%)
TSLA   798.32 (-4.25%)
AMD   47.36 (-3.58%)
T   37.38 (-1.76%)
ACB   1.49 (-3.86%)
F   7.24 (-4.36%)
NFLX   360.06 (-2.34%)
BAC   31.08 (-5.04%)
DIS   128.29 (-3.55%)
GILD   69.23 (-5.03%)
Log in

Antares Pharma Earnings Date, Estimates & History (NASDAQ:ATRS)

$3.28
-0.12 (-3.53 %)
(As of 02/25/2020 02:38 PM ET)
Today's Range
$3.26
Now: $3.28
$3.46
50-Day Range
$3.40
MA: $3.91
$4.54
52-Week Range
$2.60
Now: $3.28
$5.13
Volume823,181 shs
Average Volume1.40 million shs
Market Capitalization$534.57 million
P/E Ratio327.83
Dividend YieldN/A
Beta0.92

Earnings

Antares Pharma has confirmed that its next quarterly earnings report will be published on Tuesday, March 3rd, 2020. Antares Pharma will be holding an earnings conference call on Tuesday, March 3rd at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Antares Pharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Antares Pharma (NASDAQ:ATRS) Earnings Estimates

2020 EPS Consensus Estimate: $0.13
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203($0.02)$0.03$0.01
Q2 20203($0.01)$0.06$0.03
Q3 20203$0.02$0.07$0.05
Q4 20203$0.02$0.07$0.04
Q1 20212$0.05$0.06$0.06
Q2 20211$0.09$0.09$0.09
Q3 20212$0.10$0.11$0.11

Antares Pharma (NASDAQ ATRS) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/3/2020
(Confirmed)
      Register (Before Market Opens)
11/5/2019Q3($0.02)$0.01$0.01$26.36 million$34.31 millionTranscript
8/6/2019Q2 2019($0.04)($0.01)($0.01)$21.66 million$28.43 millionN/A
5/2/20193/31/2019($0.04)($0.03)($0.03)$17.46 million$23.29 millionN/A
2/28/2019Q4 2018($0.02)$0.04$0.04$18.36 million$18.82 millionTranscript
11/6/20189/30/2018($0.02)($0.01)($0.01)$15.13 million$17.87 millionN/A
8/7/2018Q2 2018($0.02)($0.03)($0.03)$13.70 million$14.16 millionN/A
5/8/2018Q1 2018($0.0280)($0.04)($0.04)$12.85 million$12.70 millionN/A
3/13/2018Q4 2017($0.03)($0.02)($0.02)$15.44 million$14.00 millionTranscript
11/7/2017Q3 2017($0.03)($0.03)($0.03)$14.01 million$15.10 millionN/A
8/8/2017Q2 2017($0.03)($0.02)($0.02)$12.99 million$13.42 millionListen
5/9/2017Q1 2017($0.04)($0.03)($0.03)$12.10 million$12.01 millionListen
3/14/2017Q4 2016($0.04)($0.03)($0.03)$12.77 million$14.20 millionN/A
11/9/2016Q316($0.03)($0.04)($0.04)$11.15 million$13.50 millionListen
8/9/2016Q216($0.04)($0.04)($0.04)$11.00 million$12.20 millionN/A
5/9/2016Q1($0.03)($0.05)($0.05)$11.10 million$12.30 millionN/A
3/8/2016Q415($0.03)($0.04)($0.04)$12.53 million$11.80 millionN/A
11/5/2015Q3 15($0.03)($0.04)($0.04)$10.14 million$11.09 millionN/A
8/10/2015Q215($0.03)($0.01)($0.01)$10.93 million$14.40 millionListen
5/11/2015Q115($0.04)($0.05)($0.05)$9.22 million$8.30 millionListen
3/12/2015Q414($0.05)($0.08)($0.08)$8.50 million$8.40 millionN/A
11/6/2014Q3 2014($0.07)($0.05)($0.05)$6.92 million$6.57 millionN/A
8/7/2014Q214($0.08)($0.07)($0.07)$6.43 million$6.30 millionN/A
5/9/2014Q114($0.04)($0.07)($0.07)$6.17 million$5.20 millionN/A
3/13/2014Q4 2013($0.06)($0.04)($0.04)$6.20 million$4.70 millionN/A
11/6/2013Q3 2013($0.04)($0.05)($0.05)$5.86 million$5.50 millionTranscript
8/7/2013Q2 2013($0.03)($0.04)($0.04)$5.82 million$5.84 millionTranscript
5/8/2013Q1 2013($0.01)($0.03)($0.03)$5.12 million$4.50 millionN/A
3/13/2013Q4 2012($0.03)($0.04)$5.36 million$5.50 millionTranscript
11/7/2012Q312($0.03)($0.03)$5.62 million$5.68 millionN/A
8/8/2012($0.03)($0.03)N/A
11/8/2011Q3 2011($0.01)($0.01)($0.01)N/A
8/8/2011Q2 2011($0.01)($0.02)($0.02)N/A
5/9/2011Q1 2011($0.02)($0.02)($0.02)N/A
3/14/2011Q4 2010($0.02)($0.02)($0.02)N/A
11/10/2010Q3 2010($0.02)($0.02)($0.02)N/A
8/12/2010Q2 2010($0.02)($0.02)($0.02)N/A
5/13/2010Q1 2010($0.04)($0.02)($0.02)N/A
3/23/2010Q4 2009($0.03)($0.03)($0.03)N/A
11/9/2009Q3 2009($0.03)($0.04)($0.04)N/A
8/13/2009Q2 2009($0.06)($0.03)($0.03)N/A
5/13/2009Q1 2009($0.06)($0.04)($0.04)N/A
3/25/2009Q4 2008($0.05)($0.04)($0.04)N/A
11/13/2008Q3 2008($0.06)($0.05)($0.05)N/A
8/14/2008Q2 2008($0.05)($0.05)($0.05)N/A
5/15/2008Q1 2008($0.04)($0.05)($0.05)N/A
3/26/2008Q4 2007($0.03)($0.05)($0.05)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 2/25/2020 by MarketBeat.com Staff

Featured Article: Risk Tolerance

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel